Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 5Phase 1/2 4Phase EARLY_PHASE1 2Phase 2/3 1

Status

Completed 37Terminated 20Recruiting 16Active not recruiting 7Unknown 5Withdrawn 4Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Breast 1

Conditions

Pancreatic Neoplasms 2Recurrence 1Carcinoma, Non-Small-Cell Lung 1Advanced Breast Cancer 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 28pembrolizumab 22Bevacizumab 18Fluorouracil 17Cisplatin 17Nivolumab 16Capecitabine 16Leucovorin 15Dexamethasone 14Carboplatin 13avelumab 12Oxaliplatin 12Radiosurgery 11Gemcitabine 11Rituximab 10Radiotherapy 10Lenalidomide 10ALT-803 10venetoclax 9fludarabine 9Taxes 9Omacor 9Azacitidine 9130-nm albumin-bound paclitaxel 9Paclitaxel 8Docetaxel 8Bortezomib 8fludarabine phosphate 7Melphalan 7Irinotecan 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Withdrawn × Albumin-Bound Paclitaxel × Clear all
NCT06592664 2025-06-06

FORTIFIDE

Lisata Therapeutics, Inc.

Phase 1/2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT05251038 2023-05-11

Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer

Hoosier Cancer Research Network

Phase 1/2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT04826016 2023-03-20

POLTER

MedSIR

Phase 1/2 Withdrawn
Breast

Advanced Breast Cancer

NCT03361319 2020-11-24

N3

Royal Marsden NHS Foundation Trust

Phase 1/2 Withdrawn
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡